The new Executive Leadership Team will be led by Liam Condon, who continues to serve as a member of Bayer’s Board of Management and as President of the Crop Science Division headquartered in Monheim, Germany. He is also responsible for Bayer’s Animal Health business unit. “Liam Condon brings over 25 years of experience in leading and growing businesses in the agriculture and health industries. We are convinced that he will successfully lead the combined Crop Science business,” said Werner Wenning, Chairman of the Supervisory Board of Bayer AG.

Liam Condon has been a member of the Board of Management of Bayer AG since January 2016 and President of the Crop Science division since December 2012. He is also responsible for the Animal Health Business Unit.

Monsanto Chairman and CEO Hugh Grant has announced he will leave the company after its acquisition by Bayer is completed.

Monsanto COO Brett Begemann will become Head of Commercial Operations. Dr. Robert Reiter will be Head of Research & Development. He is the current Technology Integration Planning Lead at Monsanto. Michael Schulz will become Chief Financial Officer Crop Science and Head of Finance.

The appointments will only become effective with the closing of Bayer’s acquisition of Monsanto which depends on receipt of the required regulatory approvals.